Work

Mirikizumab (Omvoh) – An IL-23 Antagonist for Crohn's Disease

Year: 2025

Type: article

Source: The medical letter on drugs and therapeutics/The medical letter

DOI: 10.58347/tml.2025.1728d

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410139005

FWCI: 0.552

Cites:

Cited by: 1

Related to: 10